Unilateral Breast Cancer

This means cancer found in only one breast, not both. It's a type of breast cancer, but it affects just one side.

Condition

What people with Unilateral Breast Cancer report

Every report comes from a Lived member, sent anonymously.

Have you had Lumpectomy for Unilateral Breast Cancer?

NameHow it went

About Unilateral Breast Cancer

What It Is

Unilateral breast cancer is breast cancer found in one breast only, either the left or the right, rather than in both breasts at once. It is not a separate type of breast cancer. The label describes where the cancer is, and the cancer itself is still defined by the cells it started in, how far it has spread and what the cells are sensitive to. Breast cancer begins when cells in the breast change and grow out of control, often forming a lump. Some cancers stay where they started (called in situ, such as ductal carcinoma in situ or DCIS), while invasive cancers grow into surrounding tissue and can spread to the lymph nodes under the arm or to other parts of the body. Many early breast cancers cause no symptoms and are found on a screening mammogram. Others show up as a new lump, a change in the shape of the breast, puckered skin or a change in the nipple. Which side the cancer is on matters for a few practical decisions: which breast is operated on, how the other breast is watched afterward, and, for cancers on the left, how radiation is planned to protect the heart.

Causes & Risk Factors

Breast cancer develops from changes in the DNA of breast cells, and for most people the exact reason those changes happened cannot be pinned down. Risk factors raise the chance of breast cancer without causing any one person's cancer, and many people diagnosed have no known risk factor beyond being female and getting older, which are the two strongest. Other recognized risk factors include a personal history of breast cancer or DCIS, dense breast tissue, radiation to the chest at a young age, longer lifetime exposure to estrogen (early periods, late menopause, a first birth at an older age or no full-term pregnancy), combined estrogen and progestin menopausal hormone therapy, excess weight after menopause, alcohol and low physical activity. Inherited changes (variants) in certain genes, most notably BRCA1 and BRCA2 and also others such as PALB2 and CHEK2, raise risk considerably. For someone who already has cancer in one breast, these variants also matter because they make a later, separate cancer in the other breast more likely, which can change surgical choices. That is one reason genetic counseling and testing are often offered at diagnosis.

How It's Diagnosed

Assessment usually starts with a clinical breast exam and a diagnostic mammogram, a more detailed set of x-ray views aimed at the area of concern. Ultrasound gives another view of the area, and MRI is sometimes added to measure the cancer or check the rest of the breast and the other side. Imaging can show that something looks suspicious, but a biopsy is the only sure way to diagnose breast cancer. Most biopsies use a needle under local anesthetic, and a tiny marker clip may be left to show where the sample was taken. The pathology report then describes the cancer in ways that steer treatment. Every breast cancer is tested for hormone receptors (estrogen and progesterone receptors, which mean the cancer uses these hormones to grow) and for HER2, a protein that drives some faster-growing cancers. The grade, from 1 to 3, describes how abnormal the cells look; a higher grade means faster likely growth. For some early hormone receptor positive cancers, a multigene test of the tumor (Oncotype DX is a common one) estimates the chance of the cancer returning and helps decide whether chemotherapy adds benefit. Staging works out how far the cancer has spread. A sentinel lymph node biopsy removes the first one or few underarm nodes the cancer would drain to, usually during surgery. Scans such as CT, bone scans or PET are used when symptoms or the size and spread of the cancer make distant spread more likely.

Treatment Options

Treatment combines local therapy, which deals with the cancer in the breast and nearby nodes, with whole-body (systemic) therapy when the risk of the cancer returning elsewhere justifies it. The plan depends on stage, the hormone receptor and HER2 results, and personal priorities. Surgery is the core of local treatment. A lumpectomy, also called breast-conserving surgery, removes the cancer with a margin of healthy tissue and is usually followed by radiation; for people whose cancer is small relative to the breast and in one area, this combination is as effective as mastectomy at preventing death from breast cancer and the cancer returning. A mastectomy removes the whole affected breast and is recommended when the cancer is large or in several areas, when radiation cannot be given, or when inherited risk is high. Reconstruction can be done at the same time or later, and some people choose to stay flat. Some people with cancer in one breast consider removing the healthy breast too. For people without an inherited gene variant or strong family history, a double mastectomy instead of a single one does not help them live longer. People still choose it for peace of mind, symmetry or to avoid future screening, so it is worth weighing the extra surgery, recovery and insurance coverage with the surgeon. Radiation usually runs once a day on weekdays for a few weeks. When the cancer is in the left breast, the heart sits just behind the treated area, and heart exposure raises the chance of heart disease years later. Teams reduce this with careful planning and often with deep-inspiration breath hold, in which the person holds a deep breath during each short treatment so the heart moves away from the beam. Systemic treatment is chosen by tumor biology. Hormone therapy, such as tamoxifen (a pill that blocks estrogen's effect on breast cells) or an aromatase inhibitor such as anastrozole (Arimidex) or letrozole (Femara), which lowers estrogen after menopause, is used for hormone receptor positive cancers, usually for at least five years. It substantially lowers the chance of recurrence, a new cancer in the other breast and death from breast cancer, but side effects such as hot flashes, night sweats and lower sex drive lead some people to stop early. Switching drugs or adjusting the dose often helps, so side effects are worth raising rather than enduring. HER2-targeted drugs such as trastuzumab (Herceptin) are used for HER2-positive cancers, and chemotherapy or immunotherapy may be given before or after surgery depending on the type and stage.

What to Expect

Most breast cancers are found before they have spread to distant organs, and outcomes then are very good. In US statistics, five-year relative survival (survival compared with people of the same age without cancer) is close to 100% when the cancer has not spread beyond the breast, about 88% when it has reached nearby lymph nodes and about 34% when it has spread to distant organs. These are population figures; an individual outlook depends on the stage, the tumor's biology and how it responds to treatment. The treatment period often runs several months. Most people go home the same day after a lumpectomy and resume ordinary activities within about two weeks; after a mastectomy, most return to normal activities in about four weeks, and longer with reconstruction. Fatigue during radiation or chemotherapy is common. Removing underarm lymph nodes or treating them with radiation can lead to lymphedema, a lasting swelling of the arm, and arm and shoulder pain or stiffness can linger. Afterward, follow-up visits are usually every 3 to 6 months at first and about once a year after five years. Mammograms continue every year on the remaining breast, and on the treated breast after a lumpectomy. Routine scans and blood tests are not part of standard follow-up when there are no symptoms. People on hormone therapy have bone density checked when taking an aromatase inhibitor, and the long course of medicine is a real part of daily life for years.

When to Seek Help

See a clinician for any new breast lump or thickening, a change in the size or shape of a breast, skin dimpling or redness, a nipple that turns inward or discharge that is not breast milk, even after a recent normal mammogram. Most such changes are not cancer, but they need checking. After treatment, contact your care team promptly rather than waiting for the next visit if you notice a new lump in either breast, the chest wall or under the arm, new arm swelling, new bone pain that does not go away, persistent shortness of breath or dry cough, or severe headaches. If you take tamoxifen and still have a uterus, report any unusual vaginal bleeding or spotting right away, since tamoxifen slightly raises the risk of uterine cancer.

Questions to Ask Your Doctor

  1. 1.What do my stage, hormone receptor and HER2 results mean for which treatments will help me most?
  2. 2.Am I a good candidate for lumpectomy with radiation, and how would my outcome and recovery compare with mastectomy?
  3. 3.Should I have genetic testing, and how would the result change my risk in the other breast and my surgical options?
  4. 4.If the cancer is on my left side, how will my radiation be planned to protect my heart?
  5. 5.What will my follow-up schedule be, and which symptoms should prompt me to call before my next visit?

Last reviewed • Oct 2026

Educational content, not medical advice.